Ascendis Pharma A (ASND) Capital Expenditures Growth (1y) (2013 - 2024)
Ascendis Pharma A (ASND) Capital Expenditures Growth (1y) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2024 |
51.73% |
| Jun 30, 2024 |
23.82% |
| Mar 31, 2024 |
81.44% |
| Dec 31, 2023 |
101.76% |
| Sep 30, 2023 |
66.69% |
| Jun 30, 2023 |
87.84% |
| Mar 31, 2023 |
72.82% |
| Dec 31, 2022 |
-107.92% |
| Sep 30, 2022 |
76.07% |
| Jun 30, 2022 |
7.83% |
| Mar 31, 2022 |
11.74% |
| Dec 31, 2021 |
15.31% |
| Sep 30, 2021 |
-134.21% |
| Jun 30, 2021 |
14.56% |
| Mar 31, 2021 |
28.38% |
| Dec 31, 2020 |
315.62% |
| Sep 30, 2020 |
-309.06% |
| Jun 30, 2020 |
-1,344.86% |
| Mar 31, 2020 |
-141.57% |
| Dec 31, 2019 |
110.42% |
